Prognostic Impact of Combined Inflammatory Markers in Patients Undergoing Percutaneous Coronary Intervention
Listen to this summary
The authors investigate the combined prognostic value of high-sensitivity C-reactive protein (hs-CRP) and the neutrophil-to-lymphocyte ratio (NLR) in predicting major adverse cardiovascular events (MACE) in patients undergoing percutaneous coronary intervention (PCI). Their findings indicate that patients with elevated levels of both inflammatory markers have the highest incidence of MACE, suggesting that a dual-marker approach may enhance risk stratification post-PCI compared to using either marker alone.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from American heart journal
View all →Jun 23, 2026 · American heart journal
DOAC Score Among Patients Receiving Vitamin K Antagonists
Jun 22, 2026 · American heart journal
Considerations for Using Atrial Fibrillation Burden as a Surrogate Endpoint A Report from the Cardiovascular Sciences Research Consortium
Jun 20, 2026 · American heart journal
Lessons Learned from the Feasibility Phase of the REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) Trial Program
Jun 20, 2026 · American heart journal
The Association of Single Ventricle Morphology with Long Term Quality of Life Among Survivors: A Report from CHD PULSE (Congenital Heart Disease Project to Understand Lifelong Survivor Experience)
Jun 19, 2026 · American heart journal
Registry of Atrial Fibrillation in Latin America: Primary Results of the LACROSS Study
Jun 17, 2026 · American heart journal
Prognostic Value of Left Ventricular Contractility Index in Patients with Coarctation of Aorta and Preserved Ejection Fraction
More in Internal Medicine
View all →Jun 25, 2026 · Blood
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial
Jun 25, 2026 · Blood
Translational Regulation of Sf1 Integrates Alternative Splicing and Hematopoietic Stem Cell Fate
Jun 25, 2026 · Blood
Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms
Jun 25, 2026 · The American journal of sports medicine
Association of Central Acetabular Osteophytes With Microinstability and Increased Combined Anteversion in Borderline Dysplasia Hips
Jun 25, 2026 · Blood
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
